Skip to main content
JAMA Network logoLink to JAMA Network
. 2024 Jun 28;5(6):e241974. doi: 10.1001/jamahealthforum.2024.1974

Errors in Table 1 and Table 3

PMCID: PMC11214113  PMID: 38941088

In the Original Investigation titled “Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans”1 published on May 31, 2024, in JAMA Health Forum, there were errors in Table 1 and Table 3. In Table 1, there were some errors in the proportions by age. In Table 3, cells containing “1 [Reference]” have been corrected to “0 [Reference].” This article was corrected online.

Reference

  • 1.Li Y, Heer AK, Sloane HS, et al. Budget impact analysis of circulating tumor DNA testing for colon cancer in commercial health and Medicare advantage plans. JAMA Health Forum. 2024;5(5):e241270. doi: 10.1001/jamahealthforum.2024.1270 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Health Forum are provided here courtesy of American Medical Association

RESOURCES